Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi

Authors: Buhendwa, L.1; Zachariah, R.2; Teck, R.1; Massaquoi, M.1; Kazima, J.3; Firmenich, P.4; Harries, A.D.5

Source: Tropical Doctor, Volume 38, Number 1, January 2008 , pp. 30-32(3)

Publisher: Royal Society of Medicine Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

This study shows that cabergoline (single oral-dose) is an acceptable, safe and effective drug for suppressing puerperal lactation. It could be of operational benefit not only for artificial feeding, but also for weaning in those that breast-feed within preventive mother-to-child HIV transmission programmes in resource-limited settings.

Document Type: Short communication

DOI: 10.1258/td.2007.060091

Affiliations: 1: Medecins sans Frontieres, Thyolo District, Malawi 2: Medecins sans Frontieres, Operational Research, Medical Department, Brussels Operational Center B-1090 Belgium 3: Thyolo District Health Services, Ministry of Health and Population, Thyolo, Malawi 4: Medecins Sans Frontieres, Operations Department, L-1617 Luxembourg 5: HIV Care and Support, Ministry of Health, Lilongwe, Malawi; London School of Hygiene and Tropical Medicine, UK

* This feature is in beta and some links may initially be displayed as numbers instead of article titles. Clicking on any of the links will take you to the recommended articles, regardless of the display of the link.

The full text article is available for purchase

$18.00 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A